Qatar Cardiometabolic Registry

Recruiting now

Conditions studied: Diabetes Mellitus, Cardiovascular Diseases

In brief

Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) are closely related. T2DM risk equivalent for CVD and it remains the major cause of death in T2DM. Thus, patients with T2DM and CVD disease are at very high-risk of CVD-related mortality. Therefore, more aggressive metabolic and hemodynamic control is required in such patients to improve the prognosis. We recently initiated a cardio-metabolic clinical service at the Heart Hospital, where T2DM patients with existing CVD are simultaneously examined by Cardiologist and Diabetologist for optimal metabolic and hemodynamic control. We would like to start a clinical registry for all patients who attend this clinical service to collect import clinical data about this population. This registry will serve an important source for future clinical research in the field.

Key facts

Study ID

NCT03394313

Run by

Hamad Medical Corporation

People needed

50000

Starts

2017-09-15

Expected to finish

2027-12-31

Last updated by the study team

2018-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 2 diabetes mellitus
• Newly diagnosed heart disease, such as ischemic heart disease, heart failure.

You may not qualify if…

• Patients who do not have type 2 diabetes mellitus
• Preexisting heart disease

Where it is running

• Hamad Medical Coorporation — Doha, Qatar (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.